Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
Name | Co-codaprin 8mg/400mg dispersible tablets |
BNF code | 0407010M0AAABAB |
Virtual Therapeutic Moiety | Co-codaprin |
Date identifier became valid | 26 May 2021 |
Previous product identifier | 322310004 |
Basis of preferred name | BAN - British Approved Name |
Date of name applicability | 4 May 2004 |
Previous name | Co-codaprin 8/400 dispersible tablets |
Basis of previous name | BAN - British Approved Name |
Prescribing status | Valid as a prescribable product |
Sugar free | ✗ |
Gluten free | ✗ |
Preservative free | ✗ |
CFC free | ✗ |
Non-availability | Actual Products not Available |
Non-availability status date | 9 Mar 2020 |
Dose form | Discrete |
Unit dose form size | 1.000 |
Unit dose form units | tablet |
Unit dose unit of measure | tablet |
Virtual Product Ingredient | |
---|---|
Ingredient | Codeine phosphate |
Basis of pharmaceutical strength | Based on Ingredient Substance |
Strength value numerator | 8.000 |
Strength value numerator unit | mg |
Virtual Product Ingredient | |
Ingredient | Aspirin |
Basis of pharmaceutical strength | Based on Ingredient Substance |
Strength value numerator | 400.000 |
Strength value numerator unit | mg |
Ontology Drug Form & Route | |
Form & Route | suspension.oral |
Dose Form | |
Formulation | Dispersible tablet |
Drug Route | |
Route | Oral |
Controlled Drug Prescribing Information | |
Controlled Drug category | Schedule 5 (CD Inv) |
Virtual Medicinal Product Packs | |
Co-codaprin 8mg/400mg dispersible tablets 100 tablet |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.